» Authors » A E Giuliano

A E Giuliano

Explore the profile of A E Giuliano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 144
Citations 2991
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Han B, Bhowmick N, Qu Y, Chung S, Giuliano A, Cui X
Oncogene . 2017 Mar; 36(28):3957-3963. PMID: 28288141
The Forkhead box C1 (FOXC1) transcription factor is involved in normal embryonic development and regulates the development and function of many organs. Most recently, a large body of literature has...
2.
Yu-Rice Y, Jin Y, Han B, Qu Y, Johnson J, Watanabe T, et al.
Oncogene . 2016 Apr; 35(41):5400-5411. PMID: 27041579
Estrogen receptor-α (ERα) mediates the essential biological function of estrogen in breast development and tumorigenesis. Multiple mechanisms, including pioneer factors, coregulators and epigenetic modifications have been identified as regulators of...
3.
Gangi A, Essner R, Giuliano A
Q J Nucl Med Mol Imaging . 2014 May; 58(2):95-104. PMID: 24835286
Sentinel lymph node biopsy (SLNB) is based on the hypothesis that the sentinel lymph node (SLN) reflects the lymph-node status and a negative SLN might allow complete axillary lymph node...
4.
van Hoesel A, Sato Y, Elashoff D, Turner R, Giuliano A, Shamonki J, et al.
Br J Cancer . 2013 May; 108(10):2033-8. PMID: 23652305
Background: Molecular pathways determining the malignant potential of premalignant breast lesions remain unknown. In this study, alterations in DNA methylation levels were monitored during benign, premalignant and malignant stages of...
5.
Wang J, Ray P, Sim M, Zhou X, Lu K, Lee A, et al.
Oncogene . 2012 Jan; 31(45):4798-802. PMID: 22249250
Human basal-like breast cancer (BLBC) is an enigmatic and aggressive malignancy with a poor prognosis. There is an urgent need to identify therapeutic targets for BLBC, because current treatment modalities...
6.
Droeser R, Frey D, Oertli D, Kopelman D, Baas-Vrancken Peeters M, Giuliano A, et al.
Breast . 2009 Mar; 18(2):109-14. PMID: 19289285
It is unknown whether there are any clinically relevant differences between volume-controlled (<30-50 ml/24h across trials) vs no/short-term drainage after axillary lymph node dissection in breast cancer surgery on outcomes...
7.
Yamano T, Kaneda Y, Hiramatsu S, Huang S, Tran A, Giuliano A, et al.
Cancer Gene Ther . 2007 Feb; 14(5):451-9. PMID: 17318199
Human telomerase reverse transcriptase (TERT) has been considered a potential tumor-associated antigen for active-specific immunotherapy. However, effective specific tumor antigen-specific immunity has been difficult to induce consistently by various TERT...
8.
Rubello D, Pelizzo M, Al-Nahhas A, Salvatori M, ODoherty M, Giuliano A, et al.
Eur J Surg Oncol . 2006 Apr; 32(9):917-21. PMID: 16621423
Aim: To evaluate the "state of art" of clinical role of sentinel lymph node (SLN) biopsy procedure in patients affected by differentiated thyroid carcinoma. Methods: All papers cited on PubMed/MEDLINE...
9.
Taback B, Chan A, Kuo C, Bostick P, Wang H, Giuliano A, et al.
Cancer Res . 2001 Dec; 61(24):8845-50. PMID: 11751407
Currently, molecular markers offer the unique opportunity to identify occult metastasis in early stage cancer patients not otherwise detected with conventional staging techniques. To date, well-characterized molecular tumor markers to...
10.
Chung M, Pisegna J, Spirt M, Giuliano A, Ye W, Ramming K, et al.
Surgery . 2001 Dec; 130(6):954-62. PMID: 11742323
Background: Optimal management of symptomatic neuroendocrine tumors that metastasize to the liver is controversial. We investigated aggressive hepatic cytoreduction and postoperative administration of octreotide long-acting release (LAR), a long-acting somatostatin...